On 22 September 2003, the Competitiveness Council adopted its own set of conclusions on reinforcing the competitiveness of the EU-based pharmaceutical industry.
These were based on the Commission’s communication of 1st July 2003 on the G10 Medicines Groups recommendations.
The Health Council is expected to adopt its own conclusions on the Commission’s G10 Communication at an upcoming meeting.
The G10 Group will continue its work until EU enlargement in May 2004.
Provisional Council’s conclusions
The Commission’s communication of 1st July 2003
